Eli Lilly Stock Has Skyrocketed. Novo Nordisk Has Crashed. 1 Number Explains Why They're Not Even Close Anymore.

The global market for obesity drugs is soaring, yet Lilly has a dominant market share.

CryptoAlerta — análise de criptomoedas e mercado em tempo real